Production of proinflammatory and regulatory monokines in hemodialysis patients shown at a single-cell level

Journal of the American Society of Nephrology

Volumn 9, Issue 9, 1998, Pages 1689-1696

  Girndt, Matthias ^b   Sester, Urban ^b   Kaul, Harald ^b   Köhler, Hans ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MONOKINE;

ADULT; AGED; ARTICLE; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIALYSIS MEMBRANE; FEMALE; FLOW CYTOMETRY; HEMODIALYSIS PATIENT; HUMAN; HUMAN CELL; INFLAMMATION; KIDNEY FAILURE; MALE; MONOCYTE; PRIORITY JOURNAL;

EID: 0031752333     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v991689     Document Type: Article

References (29)

1. Dinarello CA: Cytokines: Agents provocateurs in hemodialysis? Kidney Int 41: 683-694, 1992
2. Chatenoud L, Herbelin A, Beaurain G: Immune deficiency of the uremic patient. Adv Nephrol 29: 259-274, 1990
3. Schindler R, Linnenweber S, Schulze M: Gene expression of interleukin-1β during hemodialysis. Kidney Int 43: 712-721, 1993
4. Kudo S, Mizuno K, Hirai Y: Clearance and tissue distribution of recombinant human interleukin 1 beta in rats. Cancer Res 50: 5751-5755, 1990
5. Deppisch R, Schmitt V, Bommer J: Fluid phase generation of terminal complement complex as a novel index of biocompatibility. Kidney Int 37: 696-706, 1990
6. Pertosa G, Tarantino EA, Gesualdo L: C5b-9 generation and cytokine production in hemodialyzed patients. Kidney Int Suppl 41: S221-S225, 1993
7. Girndt M, Köhler H, Schiedhelm Weick E: Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int 47: 559-565, 1995
8. Ghysen J, De Plaen JF, van Ypersele de Strihou C: The effect of membrane characteristics on tumour necrosis factor kinetics during haemodialysis. Nephrol Dial Transplant 5: 270-274, 1990
9. Pertosa G, Gesualdo L, Bottalico D: Endotoxins modulate chronically tumour necrosis factor alpha and interleukin 6 release by uremic monocytes. Nephrol Dial Transplant 10: 328-333, 1995
10. Oettinger CW, Bland LA, Oliver JC: The effect of uremia on tumor necrosis factor alpha release after an in vitro whole-blood endotoxin challenge. J Am Soc Nephrol 4: 1890-1895, 1994
11. Pertosa G, Marfella C, Tarantino EA: Involvement of peripheral blood monocytes in haemodialysis: In vivo induction of tumour necrosis factor alpha, interleukin 6 and beta 2-microglobulin. Nephrol Dial Transplant 6[Suppl 2]: 18-23, 1991
12. Ritz E, Deppisch R, Stier E: Atherogenesis and cardiac death: Are they related to dialysis procedure and biocompatibility? Nephrol Dial Transplant 9[Suppl 2]: 165-172, 1994
13. Ridker PM, Cushman M, Stampfer MJ: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 973-979, 1997
14. Anderson J, Briefel GR, Jones JM: Effects of acetate dialysate on transforming growth factor β1, interleukin, and β2-microglobulin plasma levels. Kidney Int 40: 1110-1117, 1991
15. Cavaillon JM, Poignet JL, Fitting C: Serum interleukin-6 in long-term hemodialyzed patients. Nephron 60: 307-313, 1992
16. Papadimitriou M, Baker LR, Seitanidis B: White blood count in patients on regular haemodialysis. Br Med J 4: 67-69, 1969
17. Craddock PR, Fehr J, Dalmasso AP: Hemodialysis leukopenia: Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 59: 879-888, 1977
18. Yamaguchi T, Iwano M, Kubo A: IL-6 mRNA synthesis by peripheral blood mononuclear cells (PBMC) in patients with chronic renal failure. Clin Exp Immunol 103: 279-284, 1996
19. Jung T, Schauer U, Heusser C: Detection of intracellular cytokines by flow cytometry. J Immunol Methods 159: 197-207, 1993
20. Prussin C, Metcalfe DD: Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods 188: 117-128, 1995
21. De Caestecker MP, Telfer BA, Hutchinson IV: The detection of intracytoplasmic interleukin-1 alpha, interleukin-1 beta and tumour necrosis factor alpha expression in human monocytes using two colour immunofluorescence flow cytometry. J Immunol Methods 154: 11-20, 1992
22. Daugirdas JT, Ing TS: Handbook of Dialysis, 2nd Ed., Boston, New York, Little, Brown and Co., 1994, p 94
23. Mollenhauer HM, Morre DJ, Rowe LD: Alterations of intracellular traffic by monensin: Mechanism, specificity and relationship to toxicity. Biochim Biophys Acta 1031: 225-246, 1990
24. Memoli B, Libella C, Rampino T: Interleukin-6 production of uraemic haemodialysed patients: Effects of different membranes. Nephrol Dial Transplant 6[Suppl 2]: 96-98, 1991
25. Lonnemann G, Barndt I, Kaever V: Impaired endotoxin-induced interleukin-1 beta secretion, not total production, of mononuclear cells from ESRD patients. Kidney Int 47: 1158-1167, 1995
26. De Waal Malefyt R, Abrams J, Bennett B: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174: 1209-1220, 1991
27. Fiorentino DF, Zlotnik A, Mosmann TR: IL-10 inhibits cytokine production by activated macrophages. J Immunol 147: 3815-3822, 1991
28. Schindler R, Lonnemann G, Shaldon S: Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. Kidney Int 37: 85-93, 1990
29. Mosman TR, Sad S: The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17: 138-146, 1996